Long-term effectiveness and safety of metreleptin in the treatment of patients with partial lipodystrophy

PURPOSE: To evaluate the effects of metreleptin in patients with partial lipodystrophy (PL). METHODS: Patients aged ≥6 months with PL, circulating leptin <12.0 ng/mL, and diabetes mellitus, insulin resistance, or hypertriglyceridemia received metreleptin doses (once or twice daily) titrated to a...

詳細記述

保存先:
書誌詳細
出版年:Endocrine
主要な著者: Oral, Elif A., Gorden, Phillip, Cochran, Elaine, Araújo-Vilar, David, Savage, David B., Long, Alison, Fine, Gregory, Salinardi, Taylor, Brown, Rebecca
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7340120/
https://ncbi.nlm.nih.gov/pubmed/30805888
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12020-019-01862-8
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料